Pharmacokinetics and clinical utility of sodium bromide (NaBr) as an estimator of extracellular fluid volume in horses

Direct analysis of bromine and iodine in dried serum spots by laser ablation inductively coupled plasma mass spectrometry

RATIONALE

Accurate quantitative analysis of bromine and iodine in serum is an important aspect of monitoring body condition, but the volatile loss of halogen in sample pretreatment is a troublesome problem. We present a validated and flexible high-throughput method for quantification of bromine and iodine in dried serum spots (DSS) using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) and an external aqueous standard calibration curve. The influence of serum matrix and laser ablation (LA) conditions on the analysis of bromine and iodine in DSS was researched systematically.

METHODS

Aqueous standards without matrix matching were used for calibration to analyze bromine and iodine in serum by LA-ICP-MS. 5-μL volumes of the aqueous standard solution and serum samples in 10 times diluted concentration were deposited on the PTFE paper to form dried standard calibration spots (DSCS) and DSS, of less than 2 mm in diameter. LA was performed using a focused Nd:YAG laser beam in raster lineal scan mode.

RESULTS

The limits of detection (LODs) for bromine and iodine in DSS were 0.23 and 0.03 mg L^-1 , respectively. The relative standard deviation (RSD) for this method was less than 10%. The samples were also detected with matrix matching calibration by ICP-MS. The accuracy of the method was verified by statistical analysis of these results from ICP-MS and LA-ICP-MS. The accuracy is satisfactory with recoveries ranging from 81.5% to 118%.

CONCLUSIONS

A novel and simple approach for high-throughput screening of bromine and iodine in DSS has been established by LA-ICP-MS. Calibration could be achieved using an aqueous standard solution instead of a matrix-matching solution. The method allowed analysis of low-volume biological samples without derivatization and decreased the risk of contamination or loss.

The role of endogenous bromotyrosine in health and disease

Bromotyrosine is a stable by-product of eosinophil peroxidase activity, a result of eosinophil activation during an inflammatory immune response. The elevated presence of bromotyrosine in tissue, blood, and urine in medical conditions involving eosinophil activation has highlighted the potential role of bromotyrosine as a medical biomarker. This is highly beneficial in a paediatric setting as a urinary noninvasive biomarker. However, bromotyrosine and its derivatives may exert biological effects, such as protective effects in the brain and pathogenic effects in the thyroid. Understanding these pathways may yield therapeutic advancements in medicine. In this review, we summarize the existing evidence present in literature relating to bromotyrosine formation and metabolism, identify the biological actions of bromotyrosine and evaluate the feasibility of bromotyrosine as a medical biomarker.

Hydration status of horses performing endurance exercise: I. Evidence for a role of diet

Water and electrolyte loss from endurance exercise results in physiological disturbances in the horse. The large intestine may serve as a water reservoir and help attenuate dehydration. Dietary constituents may affect the amount of water within the intestine and available for use. This study examined the hydration status of horses fed three common diets for 14 d then subjected to a 60 km exercise test. After an initial training period, horses were assigned to a replicated 3×3 Latin Square. Diets were grass hay (G), 50:50 grass hay:alfalfa hay (GA), and 50:50 grass hay:short-chopped, fibre-based, oil-supplemented mixed feed (GM). Total body water (TBW) tended to be higher (P<0.08) in horses consuming GA and GM than G (65.8±0.8, 65.4±0.8, and 63.9±0.8%, respectively). Body mass (BM) was not different at the start of the exercise test, but when corrected for faecal loss and water intake showed a trend for diet difference during exercise (P<0.08), decreasing more in GM than G (5.1±0.4% vs. 3.4±0.4%; GA 4.2±0.4%). Heart rate was not different except at the end of bout one (after 15 km) when GM was lower than G or GA (P<0.01). Core body temperature, although not different at the start of the exercise test bout, was lower (P<0.05) at the canter in GM. As the GM diet was higher in oil, the increase in oil intake may have been responsible for the differences observed. However, more likely, the higher TBW with the GM and GA diets at the initiation of exercise, associated with more readily fermentable fibre components, may have provided a greater ‘pool’ of available water for increased thermoregulation via sweating, allowing maintenance of a lower core body temperature during exercise at the expense of increased BM loss.

A systematic review of the safety of potassium bromide in dogs

OBJECTIVE

To critically evaluate and summarize available information on the safety of potassium bromide in dogs.

DESIGN

Systematic review.

SAMPLE

111 references reporting safety information relevant to potassium bromide published between 1938 and 2011.

PROCEDURES

PubMed searches without date limitations were conducted with the terms "potassium bromide" and "sodium bromide" in December 2009 and October 2011. Additional articles were identified through examination of article reference lists and book chapters on seizures in dogs and pharmacology.

RESULTS

Reversible neurologic signs were the most consistently reported toxicoses and were generally associated with adjunctive potassium bromide treatment or high serum bromide concentrations. Dermatologic and respiratory abnormalities were rare in dogs. Insufficient information was available to assess the effects of potassium bromide on behavior or to determine the incidence of vomiting, weight gain, polyphagia, pancreatitis, polyuria, polydipsia, or reproductive abnormalities associated with potassium bromide administration. Evidence suggested that administration of potassium bromide with food may alleviate gastrointestinal irritation and that monitoring for polyphagia, thyroid hormone abnormalities, and high serum bromide concentrations may be beneficial.

CONCLUSIONS AND CLINICAL RELEVANCE

Results suggested that potassium bromide is not an appropriate choice for treatment of every dog with seizures and that practitioners should tailor therapeutic regimens and clinical monitoring to each dog. Abrupt dietary changes or fluid therapy may compromise seizure control or increase the likelihood of adverse events. Availability of an appropriately labeled, approved potassium bromide product could provide better assurance for veterinarians and their clients of the quality, safety, and effectiveness of the product for veterinary use.

A comparison of hypertonic (7.2%) and isotonic (0.9%) saline for fluid resuscitation in horses: a randomized, double-blinded, clinical trial

BACKGROUND

Hypertonic saline solution (7.2%) (HSS) can quickly replace intravascular volume deficits. HSS more recently has been advocated in the treatment of traumatic brain injury, but its use in dehydrated patients remains controversial.

HYPOTHESIS

Hypertonic saline solution will show a significant improvement in both clinical and laboratory hydration parameters as compared to isotonic (0.9%) saline solution (ISS).

ANIMALS

Endurance horses eliminated from the 2009 Western States 100-mile (220-km) endurance ride and requiring IV fluid therapy were eligible for enrollment in the study.

METHODS

Twenty-two horses were randomly assigned to receive 4 mL/kg of either HSS or ISS along with 5 L lactated Ringer's solution (LRS). After this bolus, horses were treated with additional LRS in varying amounts. Blood and urine samples were collected before, during, and after treatment. Data were compared using 2-way ANOVA with repeated measures.

RESULTS

As compared to ISS, HSS horses showed greater decreases in PCV (P = .04), total protein (P = .01), albumin (P = .01), and globulin (P = .02) concentrations. HSS horses showed greater increases in sodium and chloride (P < .001) as compared to ISS horses. Horses receiving HSS had a shorter time to urination (P = .03) and lower specific gravity (P < .001) than those receiving ISS.

CONCLUSIONS

Results of this study indicate that HSS may provide faster restoration of intravascular volume deficits than ISS in endurance horses receiving emergency medical treatment. More marked electrolyte changes should be expected with HSS, however, and additional fluids after HSS administration likely are needed.